Use of precision drugs ‘encouraging’ in prostate most cancers remedy

On this video, Alexander Chehrazi-Raffle, MD, discusses the outcomes of a examine into the usage of new precision drugs therapies in prostate most cancers, introduced at ASCO Annual Assembly.

Chehrazi-Raffle, a medical oncologist on the Metropolis of Hope Duarte Most cancers Heart, examined the NEPTUNE examine, which checked out nivolumab (Opdivo, Bristol Myers Squibb) and ipilimumab (Yervoy, Bristol Myers Squibb) in metastatic castration-resistant prostate most cancers, whereas concerning the state of precision drugs as a complete.

“Within the final 4 years, we have seen pointers adapt to include germline and somatic testing in all sufferers with metastatic illness. And we’re seeing charges of these types of assessments improve as time goes on, which is absolutely encouraging,” Chehrazi-Raffle stated.

Revealed by:

Add subject to e-mail alerts

Obtain an e-mail when new articles are posted on

Please present your e-mail handle to obtain an e-mail when new articles are posted on .

“
data-action=”subscribe”>
Subscribe

We had been unable to course of your request. Please attempt once more later. If you happen to proceed to have this problem please contact customerservice@slackinc.com.

Again to Healio